@article{TCR9630,
author = {Camillo Porta and Silvia Chiellino},
title = {Long-term safety of targeted agents used to treat metastatic renal cell carcinoma: the issue is not the rate of adverse events over time, but the expertise needed to manage them},
journal = {Translational Cancer Research},
volume = {5},
number = {Suppl 3},
year = {2016},
keywords = {},
abstract = {Targeted agents have revolutionized the treatment of advanced renal cell carcinoma (RCC), greatly improving the survival of patients affected with once orphan disease.},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/9630}
}